Literature DB >> 2337676

Human adenosine deaminase expression in mice.

K A Moore1, F A Fletcher, D K Villalon, A E Utter, J W Belmont.   

Abstract

A replication defective retroviral vector containing a human adenosine deaminase (hADA) cDNA was produced by GP + E-86 packaging cells at high titer. We report long-term expression of hADA in the hematopoietic tissues of mice transplanted with bone marrow cells infected by in vitro co-cultivation with vector producing cells. Western analysis using an hADA-specific antibody allowed detection of the protein in the peripheral blood of all 37 transplanted mice for at least 9 weeks. Sixty-eight percent of the animals continued to express hADA in one or more of their hematopoietic tissues for the experimental period, and hADA was found in both spleen colonies and tissues of secondary recipients. There was provirus integration and expression in myeloid, erythroid, and lymphoid cell lineages, indicating extensive repopulation by the progeny of infected stem cells. The vector did not contain a selectable marker, and the infected stem cells did not have a competitive in vivo advantage. Nevertheless, we observed consistent gene transfer into hematopoietic stem cells and long-term expression of a human gene product in their progeny.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2337676

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells.

Authors:  V W van Beusechem; A Kukler; P J Heidt; D Valerio
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

Review 2.  Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models.

Authors:  Andre Larochelle; Cynthia E Dunbar
Journal:  Semin Hematol       Date:  2013-04       Impact factor: 3.851

3.  Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors.

Authors:  T Moritz; V P Patel; D A Williams
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

4.  Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position.

Authors:  R C Hoeben; A A Migchielsen; R C van der Jagt; H van Ormondt; A J van der Eb
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

5.  Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo.

Authors:  P M Challita; D B Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

6.  Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells.

Authors:  I Rivière; K Brose; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

Review 7.  Gene therapy: here to stay.

Authors:  I D Dubé; D Cournoyer
Journal:  CMAJ       Date:  1995-05-15       Impact factor: 8.262

8.  Human cord blood cells as targets for gene transfer: potential use in genetic therapies of severe combined immunodeficiency disease.

Authors:  T Moritz; D C Keller; D A Williams
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

9.  Leukemia inhibitory factor improves survival of retroviral vector-infected hematopoietic stem cells in vitro, allowing efficient long-term expression of vector-encoded human adenosine deaminase in vivo.

Authors:  F A Fletcher; K A Moore; M Ashkenazi; P De Vries; P A Overbeek; D E Williams; J W Belmont
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.